Literature DB >> 1810732

Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia.

J Marin1, M A Sanz, G F Sanz, J Guarro, M L Martínez, M Prieto, E Gueho, J L Menezo.   

Abstract

A case of disseminated Scedosporium inflatum infection occurring in a neutropenic patient with acute myeloblastic leukemia is reported. Scedosporium inflatum was isolated from skin lesions, blood, urine and vitreous cultures. Amphotericin B treatment was ineffective in avoiding hematogenous spread. At autopsy, hyphae and ovoid conidia with truncate bases consistent with the morphology of Scedosporium inflatum were found in the lungs, kidneys, myocardium, liver, thyroid, spleen, lymph nodes, brain and the left eye. This is the first report of disseminated Scedosporium inflatum infection and the first time this organism has been isolated from a patient in Europe.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1810732     DOI： 10.1007/BF01972505

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  8 in total

1.  Scedosporium inflatum, an emerging pathogen.

Authors:  I F Salkin; M R McGinnis; M J Dykstra; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

2.  Chronic, recurrent osteomyelitis caused by Scedosporium inflatum.

Authors:  M Malekzadeh; G D Overturf; S B Auerbach; L Wong; M Hirsch
Journal:  Pediatr Infect Dis J       Date:  1990-05       Impact factor: 2.129

3.  A case of disseminated Scedosporium apiospermum infection after bone marrow transplantation.

Authors:  D Guyotat; M A Piens; R Bouvier; D Fiere
Journal:  Mykosen       Date:  1987-04

Review 4.  The human hematopoietic colony-stimulating factors.

Authors:  S C Clark; R Kamen
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

Review 5.  Clinical significance of Pseudallescheria boydii: a review of 10 years' experience.

Authors:  L B Travis; G D Roberts; W R Wilson
Journal:  Mayo Clin Proc       Date:  1985-08       Impact factor: 7.616

6.  Scedosporium inflatum: clinical spectrum of a newly recognized pathogen.

Authors:  C M Wilson; E J O'Rourke; M R McGinnis; I F Salkin
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

7.  Systemic pseudallescheriasis in a patient with acute myelocytic leukemia.

Authors:  A G Smith; S M Crain; C Dejongh; G M Thomas; R D Vigorito
Journal:  Mycopathologia       Date:  1985-05       Impact factor: 2.574

Review 8.  Emerging fungal pathogens.

Authors:  E J Anaissie; G P Bodey; M G Rinaldi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267
  8 in total
  14 in total

Review 1.  Developments in fungal taxonomy.

Authors:  J Guarro; A M Stchigel
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

2.  Characterization of Scedosporium prolificans clinical isolates by randomly amplified polymorphic DNA analysis.

Authors:  R San Millán; G Quindós; J Garaizar; R Salesa; J Guarro; J Pontón
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates.

Authors:  Joseph Meletiadis; Jacques F G M Meis; Johan W Mouton; Juan Luis Rodriquez-Tudela; J Peter Donnelly; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Disseminated infection caused by Scedosporium prolificans in a patient with acute multilineal leukemia.

Authors:  J de Batlle; M Motjé; R Balanzà; R Guardia; R Ortiz
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

5.  Invasive mold infections in cancer patients: 5 years' experience with Aspergillus, Mucor, Fusarium and Acremonium infections.

Authors:  V Krcmery; E Kunova; Z Jesenska; J Trupl; S Spanik; J Mardiak; M Studena; E Kukuckova
Journal:  Support Care Cancer       Date:  1996-01       Impact factor: 3.603

6.  Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.

Authors:  M Simitsopoulou; C Gil-Lamaignere; N Avramidis; A Maloukou; S Lekkas; E Havlova; L Kourounaki; D Loebenberg; E Roilides
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 7.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 8.  Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.

Authors:  Esther Benamu; Alexander Tin-Han Yu; Lijia Xie; Sebastian Fernandez-Pol; Anne Y Liu; Dora Y Ho
Journal:  Transpl Infect Dis       Date:  2017-12-21       Impact factor: 2.228

9.  Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients.

Authors:  M Alvarez; B Lopez Ponga; C Rayon; J Garcia Gala; M C Roson Porto; M Gonzalez; J V Martinez-Suarez; J L Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

10.  Ribosomal DNA internal transcribed spacer analysis supports synonomy of Scedosporium inflatum and Lomentospora prolificans.

Authors:  P A Lennon; C R Cooper; I F Salkin; S B Lee
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.